Study links exosomal microRNA to ventricular remodelling in heart failure. Discover how this biomarker could inform future ...

CANTANHEDE, PORTUGAL, NEW YORK CITY, USA AND DUBLIN, IRELAND, January 12, 2026 /EINPresswire.com/ -- • An early-phase ...

Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...

Prediabetes is an extremely heterogeneous metabolic disorder. Scientists from several partner institutes of the German Center ...

Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...

According to Adalyon’s CEO, Ulrik Zeuthen, speech-based biomarkers can be used across several applications to optimise trial ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

The DROP-FPF trial is the first Phase 3 trial in interstitial lung disease (ILD) to use automated, quantitative ...

The desire to stay young is almost instinctive. Yet in recent years, that desire has evolved beyond simple beauty or wellness, transforming into an entire industry known as longevity. In the past, ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

Accessing Testosterone Replacement Therapy shouldn’t make you want to pull your hair out (especially if that’s one of the ...

The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft ...